Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.83	24.56	33.57
Graham Fair Price	-8.41	6945.61	7583.64
PEG	89.02	-0.26	-2.34
Price/Book	-10.35	0.38	0.42
Price/Cash Flow	27.58	-3.80	-5.25
Prices/Earnings	9.56	4.40	4.02
Price/Sales	1.38	0.63	0.62
Price/FCF	27.58	-3.80	-5.25
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-13.61	0.09	0.10
Operating Margin	82.52	0.05	0.03
ROA	-23.36	< 0.005	< 0.005
ROE	0.03	0.02	-18.17
ROIC	< 0.005	0.01	43.54
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.29	< 0.005	3201.75
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.63	0.63	0.21
EPS QOQ	-0.02	-0.17	-897.77
FCF QOQ	-3.08	-0.25	91.78
Revenue QOQ	-0.07	-0.10	-47.70
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	60.83	65.13	7.07
Days Sales Outstanding (DSO)	122.41	150.22	22.72
Inventory Turnover	1.48	1.38	-6.60
Debt/Capitalization	0.37	0.44	17.45
Quick Ratio	1.08	1.21	11.20
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9846.80	9969.70	1.25
Cash	4085.70	5214.93	27.64
Capex	-69.20	-21.10	69.50
Free Cash Flow	-793.89	-995.06	-25.34
Revenue	6761.44	6053.60	-10.47
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.59	1.69	6.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.83	13.92	-17.31
Naive Interpretation	Member

06 - Financial Health · Weak

Rating